Overview


According to FutureWise analysis, the aortic stent grafts market in 2023 was valued at US$2.25 billion and is expected to reach US$3.26 billion by 2031, growing at a CAGR of 4.7%. The market's growth can be attributed to several key factors, including the rising incidence of abdominal and thoracic aortic aneurysms. The increasing acceptance of minimally invasive endovascular repair procedures, such as EVAR and TEVAR, is also contributing to this trend. Moreover, advancements in technology, particularly in the development of next-generation fenestrated and branched stent grafts, are enhancing treatment options for complex anatomical cases. Additionally, the aging population is leading to higher procedural volumes worldwide, further supporting market expansion.

An aortic stent graft is a medical device used to treat an aortic aneurysm. An aortic aneurysm is a weakening and outward bulging of the aortic wall, which is the main blood vessel responsible for carrying blood from the heart to the rest of the body. This condition can be life-threatening if the aneurysm ruptures. A stent graft is a fabric tube reinforced by a metal framework, similar to a scaffold, designed to reinforce the weakened section of the aorta. It's inserted into the aorta through a minimally invasive surgical procedure, usually through an artery in the groin. The stent graft is threaded through the arteries until it reaches the aneurysm site. Once in place, it expands, sealing off the weakened area and allowing blood to flow through the graft instead of the aneurysmal sac. This procedure is called endovascular aneurysm repair (EVAR) or endovascular aortic repair (EVAR). It is considered less invasive than traditional open surgery for repairing aortic aneurysms. EVAR generally leads to shorter hospital stays, quicker recovery times, and fewer difficulties than open surgery.

Stent grafts come in different shapes and sizes to accommodate different types and locations of aortic aneurysms. They are an important tool in modern vascular surgery for treating of aortic aneurysms and can potentially save lives by deterring aneurysm rupture. However, like any medical procedure, it carries some risks and is unsuitable for all patients. The decision to use a stent graft is based on a careful evaluation by a medical team, considering factors like the size, location, and shape of the aneurysm and the patient's overall health and anatomy.

FutureWise Market Research has published a report that provides an insightful analysis aortic stents grafts market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts aortic stents grafts market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • W.L. Gore and Associates
  • Medtronic Plc
  • Lombard Medical, Inc.
  • Endologix, Inc.
  • Terumo Corporation Inc.
  • Cardinal Health Inc.
  • Becton Dickinson and Company
  • Cryolife Inc.
  • Cook Medical, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)


Recent developments by key players in the Aortic Stents Grafts Market:

Medtronic Plc

  • In early 2024, the Endurant IIi system was globally launched, specifically designed for complex abdominal aortic aneurysms. It improves neck sealing and conformability, and is now deployed across more than 40 countries, with a registry containing over 10,000 patients.
  • Medtronic introduced an AI-driven imaging system to enhance deployment accuracy and reduce procedural complications.

Cook Medical, Inc.

  • The company introduced the Zilver PTX fenestrated graft extension, designed to maintain branch vessel patency during complex repairs, achieving a patency rate of over 93% at 12 months based on interim trial data.
  • In 2023, the Indiana facility increased its domestic production by 20% to satisfy global demand.
  • In 2023, the Zenith AlphaThoracic Stent Graft System received FDA approval for treating complex thoracic aortic aneurysms.

W.L. Gore and Associates

  • Launched the TAG Thoracic Branch Endoprosthesis, allowing for the treatment of aortic arch and descending aneurysms while preserving branch perfusion; utilized in over 1,500 cases throughout the U.S. and Europe.

Terumo Corporation Inc.

  • In May 2023, the RelayPro Thoracic Stent-Graft received FDA approval for the treatment of thoracic dissection and aneurysm, featuring a low-profile design and broad pathology coverage.

By Product

  • Abdominal Aortic Stent Graft
  • Thoracic Aortic Stent Graft

By End User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Aortic Stents Grafts Market By Product, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Aortic Stents Grafts Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Aortic Stents Grafts Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Aortic Stents Grafts Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Aortic Stents Grafts Market, By Product Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Abdominal Aortic Stent Graft
        2. Thoracic Aortic Stent Graft

  • 8.   Aortic Stents Grafts Market, By End User Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)

  • 9.   North America Aortic Stents Grafts Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2025-2033

  • 10.   Latin America Aortic Stents Grafts Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2025-2033

  • 11.   Europe Aortic Stents Grafts Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2025-2033

  • 12.   Asia Pacific Aortic Stents Grafts Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2025-2033

  • 13.   Middle East and Africa Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2025-2033

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. W.L. Gore & Associates
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Medtronic Plc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Lombard Medical, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Endologix, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Terumo Corporation Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Cardinal Health Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Becton Dickinson and Company
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Cryolife Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Cook Medical, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client

Related Market

Thoracic Aortic Stent Graft Market

Read More

Abdominal Aortic Stent Graft Market

Read More
Partner

Our Clients